BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 10489093)

  • 1. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of post exercise hypotension and sympathoinhibition in normal subjects: additional evidence for increased sympathetic outflow in borderline hypertension.
    Floras JS; Senn BL
    Can J Cardiol; 1991; 7(6):253-8. PubMed ID: 1893302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of the sympathetic nervous system to hypertension in diabetes mellitus.
    Kribben A; Philipp T
    Diabete Metab; 1989; 15(5 Pt 2):313-7. PubMed ID: 2693150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release.
    Esler MD; Jennings GL; Johns J; Burke F; Little PJ; Leonard P
    J Hypertens Suppl; 1984 Dec; 2(3):S123-5. PubMed ID: 6599657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique.
    Grassi G; Bolla GB; Seravalle G; Quarti-Trevano F; Facchetti R; Mancia G
    J Hypertens; 2008 Nov; 26(11):2185-90. PubMed ID: 18854759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sympathetic nervous system in hypertension and effects of cardiovascular drugs.
    Noll G; Wenzel RR; Binggeli C; Corti C; Lüscher TF
    Eur Heart J; 1998 Jun; 19 Suppl F():F32-8. PubMed ID: 9651733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man.
    Mörlin C; Wallin BG; Eriksson BM
    Acta Physiol Scand; 1983; 119(2):117-21. PubMed ID: 6659984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced sympathoneural responses to the cold pressor test in individuals with essential hypertension and in those genetically predisposed to hypertension. No support for the "pressor reactor" hypothesis of hypertension development.
    Lambert EA; Schlaich MP
    Am J Hypertens; 2004 Oct; 17(10):863-8. PubMed ID: 15485746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased regional sympathetic nervous activity in human hypertension: causes and consequences.
    Esler M; Lambert G; Jennings G
    J Hypertens Suppl; 1990 Dec; 8(7):S53-7. PubMed ID: 1965656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of noradrenaline in the pathogenesis of essential hypertension. Preliminary report].
    Weidmann P; Keusch G; Flammer J; Ziegler WH; Reubi FC
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1974-6. PubMed ID: 749196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic activity, blood pressure variability and end organ damage in hypertension.
    Mancia G; Di Rienzo M; Parati G; Grassi G
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S3-8. PubMed ID: 9321734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic nervous system and hypertension in diabetic patients.
    Vecchione C; Argenziano L; Fratta L; Pompeo F; Trimarco B
    Diabetes Nutr Metab; 2000 Dec; 13(6):327-31. PubMed ID: 11232757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of essential hypertension. Plasma noradrenaline, plasma renin and pressor effects of noradrenaline and angiotensin in normotensive patients and patients with essential hypertension].
    Philipp T
    Fortschr Med; 1979 Aug; 97(30-31):1315-20. PubMed ID: 468094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of sympathetic nerve activity and arterial endothelial function in pathogenesis of hypertension in patients with obstructive sleep apnea-hypopnea syndrome].
    Zhang J; Chen BY; Han JY; Cao J; Guo MN; Wang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):437-41. PubMed ID: 17673017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of sympathetic nerve activity in mild human hypertension.
    Mark AL
    J Hypertens Suppl; 1990 Dec; 8(7):S67-75. PubMed ID: 1965657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of vagosympathetic balance in obesity-induced hypertension].
    Dabiré H; Brahimi M; Hadj-Brahim F; Le Clésiau H; Attali JR; Valensi P
    Arch Mal Coeur Vaiss; 2004; 97(7-8):749-52. PubMed ID: 15506059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.